Amlexanox Active Not Recruiting Phase 2 Trials for Non-Alcoholic Fatty Liver Disease (NAFLD) / Type 2 Diabetes Mellitus / BMI >30 kg/m2 Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01975935Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients